We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Senior Women Also Benefit from Mammography Screening

By HospiMedica International staff writers
Posted on 03 Dec 2018
Women aged 75 years and older should continue getting mammograms because of the comparatively high incidence of breast cancer found in this age group, claims a new study.

Researchers at Elizabeth Wende Breast Care (Rochester, NY, USA) conducted a study that analyzed data from 763,256 screening mammography exams performed between 2007 and 2017, with screening-detected cancer diagnosed in 3,944 patients. More...
Further analysis was performed to identify the number and type of cancers diagnosed among women 75 years of age and older (average age 80.4 years), which comprised 10% of the study cohort.

The results revealed 645 malignancies diagnosed in 616 patients in the age group, a cancer detection rate of 8.4 per 1,000 exams; 82% of the malignancies diagnosed were invasive cancers, of which 63% were grade 2 or 3. In all, 98% of the cancers found were surgically treatable, and positive lymph nodes were reported at surgical excision in seven percent of the patients; but 17 cancers were not surgically treated, due to advanced patient age or overall degraded patient health. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November 2018 in Chicago (IL, USA).

“Ongoing debate exists regarding the age to cease screening mammography. Our findings provide important data demonstrating that there is value in screening women over 75 because there is a considerable incidence of breast cancer,” said lead author radiologist Stamatia Destounis, MD. “The benefits of screening yearly after age 75 continue to outweigh any minimal risk of additional diagnostic testing. Most of the tumors found in this age group were invasive, and almost all of these patients underwent surgery.”

The frequency at which women should receive screening mammography remains controversial in the United States. In 2009, the US Preventive Services Task Force (USPSTF) updated their breast cancer screening guidelines to recommend routine biennial mammography for women ages 50-74 years, based on modeling evidence suggesting that the harms of frequent screening outweigh the small estimated added benefit of annual screening. In contrast, he American Cancer Society recommends annual screening for women 40 years of age and older.

Related Links:
Elizabeth Wende Breast Care


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: 123RF

AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection

Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.